Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions.
暂无分享,去创建一个
Bernhardt L Trout | Sandeep Kumar | Neeraj J Agrawal | Bernhard Helk | Sandeep Kumar | S. Singh | B. Helk | B. Trout | Xiaoling Wang | Neeraj J. Agrawal | Satish K Singh | Xiaoling Wang
[1] Garrett M. Morris,et al. Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.
[2] C. Pace,et al. Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa. , 2007, Journal of molecular biology.
[3] S. Teichmann,et al. The importance of sequence diversity in the aggregation and evolution of proteins , 2005, Nature.
[4] Bernhardt L. Trout,et al. Design of therapeutic proteins with enhanced stability , 2009, Proceedings of the National Academy of Sciences.
[5] Sandeep Kumar,et al. Identification and Impact of Aggregation‐Prone Regions in Proteins and Therapeutic Monoclonal Antibodies , 2010 .
[6] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] Regina M Murphy,et al. Peptide aggregation in neurodegenerative disease. , 2002, Annual review of biomedical engineering.
[8] A. Giuliani,et al. Early events in protein aggregation: Molecular flexibility and hydrophobicity/charge interaction in amyloid peptides as studied by molecular dynamics simulations , 2004, Proteins.
[9] Bernhardt L Trout,et al. Aggregation-prone motifs in human immunoglobulin G. , 2009, Journal of molecular biology.
[10] R. Nussinov,et al. Folding and binding cascades: Dynamic landscapes and population shifts , 2008, Protein science : a publication of the Protein Society.
[11] Ruth Nussinov,et al. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. , 2006, Current opinion in chemical biology.
[12] J. Prausnitz,et al. The competition between protein folding and aggregation: off-lattice minimalist model studies. , 2005, Biotechnology and bioengineering.
[13] Ruth Nussinov,et al. Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: significant role of Asn ladder. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] Francesc X. Avilés,et al. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinform..
[15] Hao Chen,et al. Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential , 2007, Bioinform..
[16] Christopher M. Dobson,et al. Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.
[17] L. Tjernberg,et al. Charge Attraction and β Propensity Are Necessary for Amyloid Fibril Formation from Tetrapeptides* , 2002, The Journal of Biological Chemistry.
[18] A Caflisch,et al. A molecular dynamics approach to the structural characterization of amyloid aggregation. , 2006, Journal of molecular biology.
[19] Ruth Nussinov,et al. Computational study of the fibril organization of polyglutamine repeats reveals a common motif identified in beta-helices. , 2006, Journal of molecular biology.
[20] David Eisenberg,et al. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Nussinov,et al. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16–22, Aβ16–35, and Aβ10–35): Sequence effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Riek,et al. 3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .
[23] Jun Guo,et al. Prediction of amyloid fibril-forming segments based on a support vector machine , 2009, BMC Bioinformatics.
[24] C. Dobson,et al. Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.
[25] J. Prausnitz,et al. Effect of single-point sequence alterations on the aggregation propensity of a model protein. , 2006, Journal of the American Chemical Society.
[26] Michele Vendruscolo,et al. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.
[27] Hai-Feng Chen. Aggregation mechanism investigation of the GIFQINS cross-beta amyloid fibril , 2009, Comput. Biol. Chem..
[28] Amedeo Caflisch,et al. Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences , 2005, Protein science : a publication of the Protein Society.
[29] Michel Goedert,et al. A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone. , 2007, Protein science : a publication of the Protein Society.
[30] Kingshuk Ghosh,et al. What drives amyloid molecules to assemble into oligomers and fibrils? , 2010, Biophysical journal.
[31] K. Dill,et al. From Levinthal to pathways to funnels , 1997, Nature Structural Biology.
[32] Naresh Chennamsetty,et al. Design and application of antibody cysteine variants. , 2010, Bioconjugate chemistry.
[33] D. Bratko,et al. Competition between protein folding and aggregation: A three-dimensional lattice-model simulation , 2001 .
[34] Fabrizio Chiti,et al. Amyloid formation by globular proteins under native conditions. , 2009, Nature chemical biology.
[35] M. J. Parker,et al. Identification of amyloidogenic peptide sequences using a coarse‐grained physicochemical model , 2009, J. Comput. Chem..
[36] M. Vendruscolo,et al. The Zyggregator method for predicting protein aggregation propensities. , 2008, Chemical Society reviews.
[37] Robert A. Grothe,et al. Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.
[38] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[39] Michele Vendruscolo,et al. The distribution of residues in a polypeptide sequence is a determinant of aggregation optimized by evolution. , 2007, Biophysical journal.
[40] R. Nussinov,et al. Molecular dynamics simulations of alanine rich β‐sheet oligomers: Insight into amyloid formation , 2002, Protein science : a publication of the Protein Society.
[41] Naresh Chennamsetty,et al. Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation , 2009, PLoS ONE.
[42] Sandeep Kumar,et al. Coupling of Aggregation and Immunogenicity in Biotherapeutics: T- and B-Cell Immune Epitopes May Contain Aggregation-Prone Regions , 2011, Pharmaceutical Research.
[43] P. Carter. Potent antibody therapeutics by design , 2006, Nature Reviews Immunology.
[44] Louise C. Serpell,et al. A simple algorithm locates β‐strands in the amyloid fibril core of α‐synuclein, Aβ, and tau using the amino acid sequence alone , 2007 .
[45] R. Nussinov,et al. Folding funnels, binding funnels, and protein function , 1999, Protein science : a publication of the Protein Society.
[46] S. A. Marshall,et al. Rational design and engineering of therapeutic proteins. , 2003, Drug discovery today.
[47] Luciana Esposito,et al. Insights into stability and toxicity of amyloid-like oligomers by replica exchange molecular dynamics analyses. , 2008, Biophysical journal.
[48] Michail Yu. Lobanov,et al. Prediction of Amyloidogenic and Disordered Regions in Protein Chains , 2006, PLoS Comput. Biol..
[49] T. Arakawa,et al. Mechanisms of protein aggregation. , 2009, Current pharmaceutical biotechnology.
[50] Fabrizio Chiti,et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[51] Naresh Chennamsetty,et al. Predictive tools for stabilization of therapeutic proteins , 2009, mAbs.
[52] P. Gupta,et al. Effect of denaturant and protein concentrations upon protein refolding and aggregation: A simple lattice model , 1998, Protein science : a publication of the Protein Society.
[53] A. Rosenberg,et al. Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.
[54] Sandeep Kumar,et al. Potential aggregation prone regions in biotherapeutics , 2009, mAbs.
[55] R. Borchardt,et al. Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.
[56] Sandeep Kumar,et al. Potential Aggregation-Prone Regions in Complementarity-Determining Regions of Antibodies and Their Contribution Towards Antigen Recognition: A Computational Analysis , 2010, Pharmaceutical Research.
[57] R Nussinov,et al. Point mutations and sequence variability in proteins: Redistributions of preexisting populations , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Prausnitz,et al. Protein-folding landscapes in multichain systems. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[59] Saurabh Aggarwal,et al. What's fueling the biotech engine—2009–2010 , 2010, Nature Biotechnology.
[60] Flavio Seno,et al. Insight into the Structure of Amyloid Fibrils from the Analysis of Globular Proteins , 2006, PLoS Comput. Biol..
[61] Maarten G. Wolf,et al. Quantitative prediction of amyloid fibril growth of short peptides from simulations: calculating association constants to dissect side chain importance. , 2008, Journal of the American Chemical Society.
[62] Naresh Chennamsetty,et al. Prediction of protein binding regions , 2011, Proteins.
[63] C. Hall,et al. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[64] P. Y. Chou,et al. Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. , 1974, Biochemistry.
[65] Stavros J. Hamodrakas,et al. A protein secondary structure prediction scheme for the IBM PC and compatibles , 1988, Comput. Appl. Biosci..
[66] Michele Vendruscolo,et al. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.
[67] D. Baker,et al. The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[68] A. Baumketner,et al. Free energy landscapes for amyloidogenic tetrapeptides dimerization. , 2005, Biophysical journal.
[69] L. Serrano,et al. Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.
[70] Fred Jacobson,et al. Protein aggregation and bioprocessing , 2006, The AAPS Journal.
[71] L. Serrano,et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.
[72] Diannan Lu,et al. How native proteins aggregate in solution: a dynamic Monte Carlo simulation. , 2008, Biophysical chemistry.
[73] Brian M. Murphy,et al. Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.
[74] A. Miranker,et al. A native to amyloidogenic transition regulated by a backbone trigger , 2006, Nature Structural &Molecular Biology.
[75] Bernhardt L Trout,et al. Prediction of aggregation prone regions of therapeutic proteins. , 2010, The journal of physical chemistry. B.
[76] Dusan Bratko,et al. Protein aggregation in silico. , 2007, Trends in biotechnology.
[77] R. Leapman,et al. Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .
[78] Silvio C. E. Tosatto,et al. The PASTA server for protein aggregation prediction. , 2007, Protein engineering, design & selection : PEDS.
[79] Michele Vendruscolo,et al. Prediction of aggregation-prone regions in structured proteins. , 2008, Journal of molecular biology.
[80] Bernhardt L Trout,et al. Developability index: a rapid in silico tool for the screening of antibody aggregation propensity. , 2012, Journal of pharmaceutical sciences.
[81] C. Roberts. Kinetics of Irreversible Protein Aggregation: Analysis of Extended Lumry−Eyring Models and Implications for Predicting Protein Shelf Life , 2003 .
[82] Andreas Vitalis,et al. Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. , 2008, Journal of molecular biology.
[83] Sheldon Park,et al. Computational design of protein therapeutics. , 2008, Drug discovery today. Technologies.
[84] Salvador Ventura,et al. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[85] Salvador Ventura,et al. Prediction of "hot spots" of aggregation in disease-linked polypeptides , 2005, BMC Structural Biology.